Identification and Management of Bipolar Depression

Sponsored by CME Outfitters, LLC

Supported by an educational grant from Sunovion Pharmaceuticals Inc.

Specialty: Psychiatric Medicine

Release date: December 4, 2013

Valid through: December 4, 2014

Target Audience:

Physicians, pharmacists, and other health care professionals with an interest in mood disorders.

Program Overview:

Bipolar disorder (BPD) is a mood disorder characterized by alternating periods of depression and mania/hypomania or mixed states. Patients with BPD spend the majority of time in depressed states, so bipolar depression is, far and away, the more common presentation of bipolar disorders that psychiatrists, primary care physicians, and other clinicians see. Yet, bipolar depression is frequently misdiagnosed as major depression. Careful screening, assisted by evidence-based assessment tools such as the Mood Disorder Questionnaire, can improve diagnostic clarity and facilitate earlier, appropriate, pharmacological and psychotherapeutic management.

It is critical for clinicians to be able to offer patients with bipolar depression the best possible care and ongoing management. Physicians in practice need to be able to interpret data on emerging agents for bipolar depression, evaluate these agents’ side effect profiles, and consider how new agents may change the way they treat patients.

This CME Snack™ activity will inspire clinicians to carefully review their patients’ diagnoses of depression and screen for bipolar disorder. It will also highlight the best treatment options for patients with bipolar depression.

Credit Types

0.5 AMA PRA Category 1™ Credit Hours

0.5 Pharmacy Education Contact Hours ( 0.05 CEUs)

All other healthcare professionals completing this course will be issued a statement of participation.